查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
整形外科再生手术产品的市场规模、份额和趋势分析报告：按产品、按最终用途、按用途、按地区和细分趋势，2023-2030 年
市场调查报告书
商品编码
1321447

整形外科再生手术产品的市场规模、份额和趋势分析报告：按产品、按最终用途、按用途、按地区和细分趋势，2023-2030 年

Orthopedic Regenerative Surgical Products Market Size, Share & Trends Analysis Report By Product (Allografts, Viscosupplements), By End-use (Hospitals, ASCs), By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

整形外科再生手术产品市场的成长与趋势

Grand View Research 的最新报告显示，到 2030 年，全球整形外科再生手术产品市场预计将达到 56.3 亿美元。

预计 2023 年至 2030 年，该市场将以 4.0% 的复合年复合成长率成长。推动市场成长的主要要素包括老年人口的增加、整形外科治疗和手术的便利性以及技术的进步。例如，骨关节炎（一种整形外科疾病）被认为是老年人（70 岁及以上）慢性残疾的主要原因。在 COVID-19 大流行期间，由于医院和诊所的慢性病患者数量减少、营销和销售活动暂停、择期手术推迟、社交距离和封锁协议，对我们产品的需求下降。做过。

例如，由于大流行，Annika Therapeutics 在招募患者参加临床试验方面面临挑战，这对公司的表现和收入产生了负面影响。然而，随着疫情后择期手术的恢復，该公司的业绩和业务有所反弹。根据美国美国有约 7,800 万成年人（占总人口的 26%）被诊断出患有关节炎。关节炎的风险随着年龄的增长而增加，并且在女性中更为常见。另一个危险因子是肥胖。根据美国肥胖盛行率约为 42.4%。因此，整形外科疾病盛行率的增加、人口高龄化和肥胖病例的增加预计将推动市场成长。整形外科再生手术中使用的产品用途范围广泛，包括痛风、关节痛、纤维肌痛、关节缺损、骨关节炎、关节重建和创伤。

预计这也将有助于市场成长。市场主要企业正在采取多项策略性倡议，包括推出新的再生解决方案以缓解疾病疼痛的研发项目。例如，2021年3月，Amniox Medical, Inc.推出了临床实验药物（IND）TTAX03——由脐带和冷冻羊膜组成，用于缓解小关节骨关节炎的疼痛。我们已继续获得 FDA 批准。例如，Zimmer Biomet 提供广泛的合成整形外科再生产品和移植物组合，包括 InterGro DBM、PrimaGen Advanced 同种异体移植物和 PlatFORM 可生物吸收骨移植替代品。

整形外科再生手术产品市场报告亮点

  • 由于骨关节炎等整形外科疾病的高盛行率，市场上产品的供应量不断增加，黏液补充剂细分市场在2022年占据了最大的市场份额，约为42.59%。
  • 由于同种异体移植物的利用率不断增加，预计同种异体移植物领域在预测期内的年复合成长率为 4.1%。
  • 由于联合重建中越来越多地采用再生解决方案，联合重建领域在2022年占据用途领域最大的收入份额，达到35.66%。
  • 由于老年患者和运动医学的用途不断增加，软骨和肌腱修復领域预计在预测期内将以 4.2% 的年复合成长率增长最快。
  • 由于大多数整形外科治疗是在医院进行的，因此医院最终用途细分市场占据主导地位，2022 年占据最大收入份额，约为 49.04%。
  • 门诊手术中心 (ASC) 领域预计在预测期内将呈现 4.1% 的最快年复合成长率。
  • 市场主要参与者正在采取各种策略性倡议，例如产品开发和推出、研究与开发、区域扩张和分销网络扩张。
  • 2021 年 1 月，Stryker收购了OrthoSensor, Inc. ，私人公司。

目录

第1章调查方法与范围

  • 市场区隔和范围
  • 调查方法
  • 研究假设
  • 资讯采购
  • 资讯或资料分析
  • 市场形成与检验
  • 型号详情
  • 二手资讯清单

第2章执行摘要

第3章整形外科再生手术产品市场变数、趋势与范围

  • 市场体系预测
    • 母市场分析
    • 配套市场预测
  • 整形外科再生手术产品市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
    • 市场机会分析
    • 市场问题分析
  • 2022 年采用与成长预测图
  • 要素因素（政治/法律、经济/技术）进行 SWOT 分析
    • 政治与法律
    • 经济形势
    • 技术形势
  • 整形外科再生手术产品市场分析工具：Porter
    • 供应商议价能力：低至中等
    • 买方议价能力：中等
    • 替代品的威胁：高
  • 法律规范
    • FDA 考虑因素
    • 赎回框架
    • HCPCS编码
  • 科技趋势分析
  • 产品平臺分析
  • 骨关节炎的盛行率（2018-2030）

第4章整形外科再生手术产品市场：COVID-19 的影响分析

  • COVID-19感染疾病的影响分析
    • 疾病盛行率分析
    • 目前影响分析
    • 未来影响分析
    • 对市场参与企业的影响

第5章整形外科再生手术产品市场：細項分析，依产品，2018-2030

  • 2022 年及 2030 年产品市占率分析
  • 整形外科再生手术产品市场（分产品），2018-2030
  • 同种异体移植物
  • 合成
  • 基于细胞的
  • 黏性补充剂

第6章2018-2030 年整形外科再生手术产品市场分析（按用途）（收入）

  • 2022 年和 2030 年用途市占率分析
  • 整形外科再生手术产品市场（按用途），2018-2030
  • 整形外科疼痛管理
  • 创伤修復
  • 软骨和肌腱修復
  • 关节重建
  • 其他的

第7章整形外科再生手术产品市场：細項分析，依最终用途，2018-2030

  • 2022 年及 2030 年最终用途市占率分析
  • 整形外科再生手术产品市场，依最终用途，2018-2030 年
  • 医院
  • 门诊手术中心
  • 其他的

第8章整形外科再生手术产品市场：2018-2030 年区域市场分析

  • 2022 年及 2030 年区域市占率分析
  • 区域市场简介
  • 北美洲
    • 2018年至2030年北美整形外科再生手术产品市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018年至2030年欧洲整形外科和再生手术产品市场估计和预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 2018年至2030年亚太地区整形外科和再生手术产品市场估计和预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 拉丁美洲整形外科再生手术产品市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA整形外科再生手术产品市场，2018-2030
    • 南非
    • 沙乌地阿拉伯

第9章整形外科再生手术产品市场-公司简介

  • 公司简介
    • Baxter
    • Zimmer Biomet
    • Stryker
    • Smith+Nephew
    • Allosource
    • Amniox Medical, Inc.
    • Anika Therapeutics, Inc.
    • Vericel Corporation
    • Vsy Biotechnology Gmbh
    • Aptissen SA
    • Mimedx
  • 市场参与企业分类
  • 上市公司
    • 创新者
    • 市场领导者
    • 公司市场分析
    • 协同效应分析：重大交易与策略联盟
  • 私人公司
    • 私人公司名单
Product Code: GVR-4-68039-477-3

Orthopedic Regenerative Surgical Products Market Growth & Trends

The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.63 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at an attractive CAGR of 4.0% from 2023 to 2030. The primary factors boosting the market growth include the growing older population, easy availability of orthopedic treatments & procedures, and technological advancements. For instance, osteoarthritis, an orthopedic ailment, has been considered the major factor of chronic disability in the geriatric population (aged above 70 years). The product demand was reduced during the COVID-19 pandemic owing to the low volume of patient flow for chronic ailments in hospitals & clinics, abated marketing & sales activities, postponed elective surgeries, social distancing, and lockdown protocols.

For example, Anika Therapeutics notified challenges in patient enrollment for its clinical trials owing to the pandemic, which adversely impacted the company's operating results and revenue. However, the company recovered financial performance and operations as elective surgeries restarted post-pandemic. As per the Centers for Disease Control and Prevention (CDC), approximately 78 million adults in the U.S., or 26% of the population, are projected to be diagnosed with arthritis by 2040. The risk of arthritis increases with age and is found to be more common in females. Another risk factor is obesity. According to the CDC, the prevalence of obesity in the U.S. was estimated to be around 42.4% from 2017 to 2018. Thus, the growing prevalence of orthopedic ailments and the rising aging population & obesity cases are expected to drive market growth. The products used in orthopedic regenerative surgery have a wide range of applications, including gout, joint pain, fibromyalgia, articular defects, osteoarthritis, joint replacement, and trauma.

This is also anticipated to contribute to the growth of the market. Key players in the market are involved in several strategic initiatives, including R&D projects to introduce new regenerative solutions for pain relief from diseases. For instance, in March 2021, Amniox Medical, Inc., received FDA clearance to proceed with a dosing study using its Investigational New Drug (IND) TTAX03- consisting of the umbilical cord and cryopreserved amniotic membrane, to alleviate facet joint osteoarthritis pain. The market participants offer a wide range of orthopedic products; for instance, Zimmer Biomet provides a wide portfolio of synthetic orthopedic regenerative products and allografts, such as the InterGro DBM, PrimaGen Advanced allograft, and PlatFORM bioresorbable bone graft substitute.

Orthopedic Regenerative Surgical Products Market Report Highlights

  • The viscosupplements segment held the largest market share of about 42.59% in 2022 owing to the high prevalence of orthopedic conditions, such as osteoarthritis, and increasing product availability in the market
  • The allografts segment is anticipated to witness a CAGR of 4.1% during the forecast period owing to the increasing utilization of allografts
  • The joint reconstruction segment held the largest revenue share of 35.66% in 2022 in the application segment due to the rising adoption of regenerative solutions in joint reconstruction
  • The cartilage & tendon repair segment is estimated to grow at the fastest CAGR of 4.2% during the forecast period owing to increasing applications in geriatric patients and sports medicine
  • The hospital end-use segment dominated the market and held the largest revenue share of about 49.04% in 2022 as most orthopedic treatments are performed in hospital settings
  • The ambulatory surgical centers (ASCs) segment is expected to showcase the fastest CAGR of 4.1% during the forecast period
  • Key players in the market are undertaking various strategic initiatives, including product development & launches, R&D, regional expansion, and distribution network expansion
  • In January 2021, Stryker acquired OrthoSensor, Inc., a private company that specializes in sensor technology and musculoskeletal care

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Research Assumptions
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Market Formulation & Validation
    • 1.5.2 Data Analysis Models
  • 1.6 Market Formulation & Validation
    • 1.6.1 Primary Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
  • 1.8 List Of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Orthopedic Regenerative Surgical Products Market Summary

Chapter 3 Orthopedic Regenerative Surgical Products Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Orthopedic Regenerative Surgical Products Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challenge Analysis
  • 3.3 Penetration And Growth Prospect Mapping,2022
  • 3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 3.4.1 Political & Legal
    • 3.4.2 Economic Landscape
    • 3.4.3 Technology Landscape
  • 3.5 Orthopedic Regenerative Surgical Products Market Analysis Tools: Porters
    • 3.5.1 Bargaining Power Of Suppliers: Low To Moderate
    • 3.5.2 Bargaining Power Of Buyers: Moderate
    • 3.5.3 Threat Of Substitutes: High
  • 3.6 Regulatory Framework
    • 3.6.1 Fda Consideration
    • 3.6.2 Reimbursement Framework
    • 3.6.3 Hcpcs Coding
  • 3.7 Technology Trend Analysis
  • 3.8 Product Pipeline Analysis
  • 3.9 Osteoarthritis Prevalence (2018 to 2030)

Chapter 4 Orthopedic Regenerative Surgical Products Market: COVID-19 Impact Analysis

  • 4.1 COVID-19 Impact Analysis
    • 4.1.1 Disease Prevalence Analysis
    • 4.1.2 Current Impact Analysis
    • 4.1.3 Future Impact Analysis
    • 4.1.4 Impact On Market Players

Chapter 5 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 5.1 Product Market Share Analysis,2022 & 2030
  • 5.2 Orthopedic Regenerative Surgical Products Market, by Product, 2018 to 2030
  • 5.3 Allograft
    • 5.3.1 Allograft Market, 2018 - 2030 (USD Million)
      • 5.3.1.1 Amniotic Products
      • 5.3.1.1.1 Amniotic Products Market, 2018 - 2030 (USD Million)
    • 5.3.2 Others
      • 5.3.2.1 Others Market, 2018 - 2030 (USD Million)
  • 5.4 Synthetic
    • 5.4.1 Synthetic Market, 2018 - 2030 (USD Million)
  • 5.5 Cell-Based
    • 5.5.1 Cell-Based Market, 2018 - 2030 (USD Million)
  • 5.6 Viscosupplement
    • 5.6.1 Viscosupplement Market, 2018 - 2030 (USD Million)

Chapter 6 Orthopedic Regenerative Surgical Products Market Analysis, By Application, 2018 - 2030 (Revenue, USD Million)

  • 6.1 Application Market Share Analysis,2022 & 2030
  • 6.2 Orthopedic Regenerative Surgical Products Market, By Application, 2018 To 2030
  • 6.3 Orthopedic Pain Management
    • 6.3.1 Orthopedic Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Trauma Repair
    • 6.4.1 Trauma Repair Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 Cartilage And Tendon Repair
    • 6.5.1 Cartilage And Tendon Repair Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6 Joint Reconstruction
    • 6.6.1 Joint Reconstruction Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7 Others
    • 6.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By End-Use, 2018 - 2030 (USD Million)

  • 7.1 End-Use Market Share Analysis, 2022 & 2030
  • 7.2 Orthopedic Regenerative Surgical Products Market, By End-Use, 2018 To 2030
  • 7.3 Hospitals
    • 7.3.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Ambulatory Surgery Centers
    • 7.4.1 Ambulatory Surgery Center Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Orthopedic Regenerative Surgical Products Market: Regional Market Analysis 2018 - 2030 (USD Million)

  • 8.1 Regional Market Share Analysis, 2022 & 2030
  • 8.2 Regional Market Snapshot
  • 8.3 North America
    • 8.3.1 North America orthopedic regenerative surgical products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.3.3 Canada
      • 8.3.3.1 Canada Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe orthopedic regenerative surgical products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 UK
      • 8.4.2.1 UK orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.3 Germany
      • 8.4.3.1 Germany orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.4 France
      • 8.4.4.1 France orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.5 Italy
      • 8.4.5.1 Italy orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.6 Spain
      • 8.4.6.1 Spain orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific orthopedic regenerative surgical products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Japan
      • 8.5.2.1 Japan orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.3 China
      • 8.5.3.1 China orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.4 India
      • 8.5.4.1 India orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.5 Australia
      • 8.5.5.1 Australia orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.5 South Korea
      • 8.5.4.1 South Korea orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • 8.6 Latin America
    • 8.6.1 Latin America orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.6.2 Brazil
      • 8.6.2.1 Brazil Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
    • 8.6.3 Mexico
      • 8.6.3.1 Mexico orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.6.4 Argentina
      • 8.6.4.1 Argentina Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • 8.7 MEA
    • 8.7.1 MEA orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.7.2 South Africa
      • 8.7.2.1 South Africa Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
    • 8.7.3 Saudi Arabia
      • 8.7.3.1 Saudi Arabia Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)

Chapter 9 Orthopedic Regenerative Surgical Products Market - Company Profiles

  • 9.1 Company Profiles
    • 9.1.1 Baxter
      • 9.1.1.1 Company Overview
      • 9.1.1.2 Financial Performance
      • 9.1.1.3 Product Benchmarking
      • 9.1.1.4 Strategic Initiatives
    • 9.1.2 Zimmer Biomet
      • 9.1.2.1 Company Overview
      • 9.1.2.2 Financial Performance
      • 9.1.2.3 Product Benchmarking
      • 9.1.2.4 Strategic Initiatives
    • 9.1.3 Stryker
      • 9.1.3.1 Company Overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 Product Benchmarking
      • 9.1.3.4 Strategic Initiatives
    • 9.1.4 Smith+Nephew
      • 9.1.4.1 Company Overview
      • 9.1.4.2 Financial Performance
      • 9.1.4.3 Product Benchmarking
      • 9.1.4.4 Strategic Initiatives
    • 9.1.5 Allosource
      • 9.1.5.1 Company Overview
      • 9.1.5.2 Financial Performance
      • 9.1.5.3 Product Benchmarking
      • 9.1.5.4 Strategic Initiatives
    • 9.1.6 Amniox Medical, Inc.
      • 9.1.6.1 Company Overview
      • 9.1.6.2 Financial Performance
      • 9.1.6.3 Product Benchmarking
      • 9.1.6.4 Strategic Initiatives
    • 9.1.7 Anika Therapeutics, Inc.
      • 9.1.7.1 Company Overview
      • 9.1.7.2 Financial Performance
      • 9.1.7.3 Product Benchmarking
      • 9.1.7.4 Strategic Initiatives
    • 9.1.8 Vericel Corporation
      • 9.1.8.1 Company Overview
      • 9.1.8.2 Financial Performance
      • 9.1.8.3 Product Benchmarking
      • 9.1.8.4 Strategic Initiatives
    • 9.1.9 Vsy Biotechnology Gmbh
      • 9.1.9.1 Company Overview
      • 9.1.9.2 Financial Performance
      • 9.1.9.3 Product Benchmarking
      • 9.1.9.4 Strategic Initiatives
    • 9.1.10 Aptissen S.A
      • 9.1.10.1 Company Overview
      • 9.1.10.2 Financial Performance
      • 9.1.10.3 Product Benchmarking
      • 9.1.10.4 Strategic Initiatives
    • 9.1.11 Mimedx
      • 9.1.11.1 Company Overview
      • 9.1.11.2 Financial Performance
      • 9.1.11.3 Product Benchmarking
      • 9.1.11.4 Strategic Initiatives
  • 9.2 Market Participant Categorization
  • 9.3 Public Companies
    • 9.3.1 Innovators
    • 9.3.2 Market Leaders
    • 9.3.3 Company Market Position Analysis
    • 9.3.4 Synergy Analysis: Major Deals & Strategic Alliances
  • 9.4 Private Companies
    • 9.4.1 List Of Private Companies

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of the key regulations, directives by countries
  • Table 3 List of private companies
  • Table 4 North America orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 6 North America orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 10 U.S. orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Canada orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 14 Canada orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 18 Europe orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 20 UK orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 21 UK orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 22 UK orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 23 UK orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 25 Germany orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 26 Germany orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 29 France orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 30 France orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 31 France orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 34 Italy orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 38 Spain orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 39 Spain orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Japan orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 46 Japan orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 47 Japan orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 48 China orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 49 China orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 50 China orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 51 China orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 52 India orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 53 India orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 54 India orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 55 India orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 58 Australia orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 59 Australia orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 62 South Korea orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 63 South Korea orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Latin America orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 65 Latin America orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 66 Latin America orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 70 Brazil orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Mexico orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 73 Mexico orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 74 Mexico orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 75 Mexico orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 78 Argentina orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 80 MEA orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 81 MEA orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 82 MEA orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 83 MEA orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa orthopedic regenerative surgical products market, by component, 2018 - 2030 (USD Million)
  • Table 85 South Africa orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 86 South Africa orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 87 South Africa orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 88 South Africa orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Orthopedic Regenerative Surgical Products market segmentation
  • Fig. 2 Methodology
  • Fig. 3 Market research process
  • Fig. 4 Data triangulation techniques
  • Fig. 5 Primary research pattern
  • Fig. 6 Primary research pattern
  • Fig. 7 Market research approaches
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modeling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Orthopedic Regenerative Surgical Products Market outlook (2022, USD Million)
  • Fig. 12 Parent market analysis
  • Fig. 13 Ancillary market analysis
  • Fig. 14 Orthopedic regenerative surgical products market dynamics analysis
  • Fig. 15 Orthopedic regenerative surgical products market driver analysis
  • Fig. 16 Common causes of spinal injury, 2018
  • Fig. 17 Orthopedic regenerative surgical products market restraint impact
  • Fig. 18 Penetration & growth prospect mapping by end-use, 2022
  • Fig. 19 Ortho regenerative technologies: Product pipeline analysis
  • Fig. 20 COVID-19 confirmed cases around the world
  • Fig. 21 Orthopedic Regenerative Surgical Products market: Product movement analysis
  • Fig. 22 Orthopedic Regenerative Surgical Products market product outlook: Key takeaways
  • Fig. 23 Allograft market, 2018 - 2030 (USD Million)
  • Fig. 24 Amniotic products market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 Synthetic market, 2018 - 2030 (USD Million)
  • Fig. 27 Cell-based market, 2018 - 2030 (USD Million)
  • Fig. 28 Viscosupplement market, 2018 - 2030 (USD Million)
  • Fig. 29 Orthopedic Regenerative Surgical Products market: Application movement analysis
  • Fig. 30 Orthopedic Regenerative Surgical Products market application outlook: Key takeaways
  • Fig. 31 Global orthopedic pain management market, 2018 - 2030 (USD Million)
  • Fig. 32 Global trauma market, 2018 - 2030 (USD Million)
  • Fig. 33 Global cartilage and tendon repair market, 2018 - 2030 (USD Million)
  • Fig. 34 Global joint reconstruction market, 2018 - 2030 (USD million)
  • Fig. 35 Global others market, 2018 - 2030 (USD Million)
  • Fig. 36 Orthopedic Regenerative Surgical Products market: End-use movement analysis
  • Fig. 37 Orthopedic Regenerative Surgical Products market end-use outlook: Key takeaways
  • Fig. 38 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 39 Global ambulatory surgery center market, 2018 - 2030 (USD Million)
  • Fig. 40 Global others market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional outlook, 2022 & 2030
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 46 Europe orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 47 UK orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 48 Germany orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 49 France orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 54 China orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 55 India orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 65 Market participant categorization
  • Fig. 66 Orthopedic regenerative surgical products: Company market position analysis
  • Fig. 67 Strategy mapping